These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The case for prostate cancer screening. Andriole GL Semin Urol; 1993 May; 11(2):50-3. PubMed ID: 7689738 [TBL] [Abstract][Full Text] [Related]
5. Early detection of prostate cancer. Role of prostate-specific antigen. Prabhakaran VM Can Fam Physician; 1996 Apr; 42():709-12. PubMed ID: 8653039 [TBL] [Abstract][Full Text] [Related]
6. The Will Rogers phenomenon in prostate cancer: a good thing. Gomella LG Cancer J Sci Am; 1998; 4(1):19-21. PubMed ID: 9467040 [No Abstract] [Full Text] [Related]
7. [Prostatic specific antigen in practice in 1997]. Salomon L; Colombel M; Patard JJ; Chopin D; Abbou CC Ann Urol (Paris); 1998; 32(2):69-72. PubMed ID: 9599634 [TBL] [Abstract][Full Text] [Related]
8. Prostate cancer screening: accepting the consequences of PSA testing. Chisholm GD Br J Urol; 1993 Apr; 71(4):375-7. PubMed ID: 7684648 [No Abstract] [Full Text] [Related]
9. PSA screening and prostate cancer incidence. Rhoads GG; Mills OF JAMA; 1996 Apr; 275(15):1155-6. PubMed ID: 8609675 [No Abstract] [Full Text] [Related]
10. PSA screening and prostate cancer incidence. Berman JJ; Moore GW; Alonsozana EL; Brown LA JAMA; 1996 Apr; 275(15):1155-6. PubMed ID: 8609674 [No Abstract] [Full Text] [Related]
11. Screening by the prostate-specific antigen test: what do the patients know? Diefenbach PN; Ganz PA; Pawlow AJ; Guthrie D J Cancer Educ; 1996; 11(1):39-44. PubMed ID: 8777154 [TBL] [Abstract][Full Text] [Related]
12. Use of prostate-specific antigen (PSA) and PSA density in the detection of stage T1 carcinoma of the prostate. Presti JC; Carroll PR Semin Urol Oncol; 1996 Aug; 14(3):134-8. PubMed ID: 8865474 [TBL] [Abstract][Full Text] [Related]
13. Study concludes that moderate PSA levels are unrelated to prostate cancer outcomes. Vastag B JAMA; 2002 Feb; 287(8):969-70. PubMed ID: 11866626 [No Abstract] [Full Text] [Related]
14. [Examination of serum prostate specific antigen (PSA) in the mass screening for prostatic diseases]. Kato M; Okada K Hinyokika Kiyo; 1993 Mar; 39(3):221-3. PubMed ID: 7685140 [TBL] [Abstract][Full Text] [Related]
15. Screening for prostate cancer in 2006: PSA in the 21st century. Maroni PD; Crawford ED N C Med J; 2006; 67(2):136-9. PubMed ID: 16752718 [No Abstract] [Full Text] [Related]
16. Prostate cancer: who to screen, and what the results mean. Small EJ Geriatrics; 1993 Dec; 48(12):28-30, 35-8. PubMed ID: 7504646 [TBL] [Abstract][Full Text] [Related]
17. Re: E. David Crawford, Per-Anders Abrahamsson. PSA-based screening for prostate cancer: how does it compare with other cancer screening tests? Eur Urol 2008;54:262-73. Kvåle R; Hernes E; Bray F Eur Urol; 2009 May; 55(5):e88-9; author reply e90-1. PubMed ID: 19062155 [No Abstract] [Full Text] [Related]
18. Mixed response to new PSA screening study. Phillips P JAMA; 1998 Jul; 280(1):8-9. PubMed ID: 9660345 [No Abstract] [Full Text] [Related]
20. Screening for prostate cancer utilizing the prostate-specific antigen (PSA). Halperin EC N C Med J; 1993 Sep; 54(9):443-6. PubMed ID: 7694161 [No Abstract] [Full Text] [Related] [Next] [New Search]